Exchange: NASDAQ·Updated 07:30 PM EST

About BLRX

About

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
24

Frequently Asked Questions

Advertisement|Remove ads.